117 related articles for article (PubMed ID: 27064430)
41. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
Hisada M; Chen BE; Jaffe ES; Travis LB
J Natl Cancer Inst; 2007 Feb; 99(3):215-22. PubMed ID: 17284716
[TBL] [Abstract][Full Text] [Related]
42. Epidemiology and familial risk of synchronous and metachronous colorectal cancer: a population-based study in Utah.
Samadder NJ; Curtin K; Wong J; Tuohy TM; Mineau GP; Smith KR; Pimentel R; Pappas L; Boucher K; Garrido-Laguna I; Provenzale D; Burt RW
Clin Gastroenterol Hepatol; 2014 Dec; 12(12):2078-84.e1-2. PubMed ID: 24768809
[TBL] [Abstract][Full Text] [Related]
43. CTG repeat lengths of the DMPK gene in myotonic dystrophy patients compared to healthy controls in Thailand.
Theerasasawat S; Papsing C; Pulkes T
J Clin Neurosci; 2010 Dec; 17(12):1520-2. PubMed ID: 20801043
[TBL] [Abstract][Full Text] [Related]
44. High Risk of Fatal and Nonfatal Venous Thromboembolism in Myotonic Dystrophy.
Sochala M; Porcher R; Stojkovic T; Bécane HM; Béhin A; Laforêt P; Bassez G; Leonard-Louis S; Eymard B; Furling D; Duboc D; Wahbi K
Circulation; 2018 Sep; 138(11):1169-1171. PubMed ID: 30354391
[No Abstract] [Full Text] [Related]
45. Family history of cancer and childhood rhabdomyosarcoma: a report from the Children's Oncology Group and the Utah Population Database.
Lupo PJ; Danysh HE; Plon SE; Curtin K; Malkin D; Hettmer S; Hawkins DS; Skapek SX; Spector LG; Papworth K; Melin B; Erhardt EB; Grufferman S; Schiffman JD
Cancer Med; 2015 May; 4(5):781-90. PubMed ID: 25809884
[TBL] [Abstract][Full Text] [Related]
46. Diagnostic value of ophthalmologic findings in myotonic dystrophy: comparison with risks calculated by haplotype analysis of closely linked restriction fragment length polymorphisms.
Ashizawa T; Hejtmancik JF; Liu J; Perryman MB; Epstein HF; Koch DD
Am J Med Genet; 1992 Jan; 42(1):55-60. PubMed ID: 1364051
[TBL] [Abstract][Full Text] [Related]
47. Familiality of cardiovascular mortality in end-stage renal disease patients.
Naiman N; Cheung AK; Goldfarb-Rumyantzev AS
Am J Nephrol; 2009; 29(3):237-43. PubMed ID: 18799871
[TBL] [Abstract][Full Text] [Related]
48. A cohort study of cancer risk in relation to family histories of cancer in the Utah population database.
Kerber RA; O'Brien E
Cancer; 2005 May; 103(9):1906-15. PubMed ID: 15779016
[TBL] [Abstract][Full Text] [Related]
49. [Clinical, familial and hereditary analysis of myotonic dystrophy].
Wu Z; Yang J; Cao J; Hu Z; Zhan Y; Li J; Li Y; Wang Y; Zhang C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 36(6):520-4. PubMed ID: 21743143
[TBL] [Abstract][Full Text] [Related]
50. Television viewing and time spent sedentary in relation to cancer risk: a meta-analysis.
Schmid D; Leitzmann MF
J Natl Cancer Inst; 2014 Jul; 106(7):. PubMed ID: 24935969
[TBL] [Abstract][Full Text] [Related]
51. Myotonic dystrophy with no trinucleotide repeat expansion.
Thornton CA; Griggs RC; Moxley RT
Ann Neurol; 1994 Mar; 35(3):269-72. PubMed ID: 8122879
[TBL] [Abstract][Full Text] [Related]
52. The risk of cancer following hospitalization for infection in infancy: a population-based cohort study.
Paltiel O; Laniado DE; Yanetz R; Deutsch L; Calderon-Margalit R; Harlap S; Friedlander Y
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1964-8. PubMed ID: 17035406
[TBL] [Abstract][Full Text] [Related]
53. Risk of second malignant neoplasms among lymphoma patients with a family history of cancer.
Landgren O; Pfeiffer RM; Stewart L; Gridley G; Mellemkjaer L; Hemminki K; Goldin LR; Travis LB
Int J Cancer; 2007 Mar; 120(5):1099-102. PubMed ID: 17131330
[TBL] [Abstract][Full Text] [Related]
54. Myasthenia gravis and thymoma coexisting with myotonic dystrophy type 1.
Ekmekci O; Karasoy H; Bademkiran F; Akkus DE; Yuceyar N
Neuromuscul Disord; 2014 Jan; 24(1):40-2. PubMed ID: 24291332
[TBL] [Abstract][Full Text] [Related]
55. Utah Population Database: a tool to study the hereditary element of nonsyndromic neurosurgical diseases.
Niazi TN; Cannon-Albright LA; Couldwell WT
Neurosurg Focus; 2010 Jan; 28(1):E1. PubMed ID: 20043712
[TBL] [Abstract][Full Text] [Related]
56. Shank sign in myotonic dystrophy type-1 (DM-1).
Pradhan S
J Clin Neurosci; 2007 Jan; 14(1):27-32. PubMed ID: 17092719
[TBL] [Abstract][Full Text] [Related]
57. Myotonic dystrophy: from bench to bedside.
Johnson NE; Heatwole CR
Semin Neurol; 2012 Jul; 32(3):246-54. PubMed ID: 23117949
[TBL] [Abstract][Full Text] [Related]
58. Muscle surface mechanical and electrical activities in myotonic dystrophy.
Orizio C; Esposito F; Sansone V; Parrinello G; Meola G; Veicsteinas A
Electromyogr Clin Neurophysiol; 1997; 37(4):231-9. PubMed ID: 9208218
[TBL] [Abstract][Full Text] [Related]
59. Population-based risk assessment for other cancers in relatives of hereditary prostate cancer (HPC) cases.
Albright LA; Schwab A; Camp NJ; Farnham JS; Thomas A
Prostate; 2005 Sep; 64(4):347-55. PubMed ID: 15754348
[TBL] [Abstract][Full Text] [Related]
60. Comparison of different methods for spatial analysis of cancer data in Utah.
Ball W; LeFevre S; Jarup L; Beale L
Environ Health Perspect; 2008 Aug; 116(8):1120-4. PubMed ID: 18709141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
